RENAL OUTCOMES IN POST-LIVER TRANSPLANT RECIPIENTS TREATED WITH TENOFOVIR ALAFENAMIDE COMPARED WITH TENOFOVIR DISOPROXIL FUMARATE AND ENTECAVIR

被引：0
|
作者：
Liu, Joanne [1 ]
Vutien, Philip [2 ]
Huang, Daniel [3 ,4 ]
Ishigami, Masatoshi [5 ]
Daniel, Peter Chen Yang Nikhil [6 ]
Ito, Takanori [5 ]
Dang, Hansen [7 ]
Maeda, Mayumi [7 ]
Leong, Jennifer [8 ]
Landis, Charles [9 ]
Nguyen, Mindie H. [7 ]
机构：
[1] Univ Washington, Seattle, WA 98195 USA
[2] Univ Washington, Div Gastroenterol, Seattle, WA 98195 USA
[3] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Med, Singapore, Singapore
[4] Natl Univ Singapore Hosp, Div Gastroenterol & Hepatol, Singapore, Singapore
[5] Nagoya Univ, Dept Gastroenterol & Hepatol, Grad Sch Med, Nagoya, Aichi, Japan
[6] Natl Univ Singapore Hosp, Dept Med, Singapore, Singapore
[7] Stanford Univ, Med Ctr, Div Gastroenterol & Hepatol, Stanford, CA 94305 USA
[8] Icahn Sch Med Mt Sinai, Dept Med, Div Liver Dis, Recanati Miller Transplantat Inst, New York, NY 10029 USA
[9] Univ Washington, Div Gastroenterol & Hepatol, Seattle, WA 98195 USA
来源：
HEPATOLOGY | 2021年 / 74卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
802
引用
收藏
页码：492A / 493A
页数：2
相关论文
共 50 条
  • [1] Retreatment Efficacy and Renal Safety of Tenofovir Alafenamide, Entecavir, and Tenofovir Disoproxil Fumarate After Entecavir or Tenofovir Cessation
    Shao-Ming Chiu
    Kuo-Chin Chang
    Tsung-Hui Hu
    Chao-Hung Hung
    Jing-Houng Wang
    Sheng-Nan Lu
    Chien-Hung Chen
    Digestive Diseases and Sciences, 2023, 68 : 665 - 675
  • [2] Retreatment Efficacy and Renal Safety of Tenofovir Alafenamide, Entecavir, and Tenofovir Disoproxil Fumarate After Entecavir or Tenofovir Cessation
    Chiu, Shao-Ming
    Chang, Kuo-Chin
    Hu, Tsung-Hui
    Hung, Chao-Hung
    Wang, Jing-Houng
    Lu, Sheng-Nan
    Chen, Chien-Hung
    DIGESTIVE DISEASES AND SCIENCES, 2023, 68 (02) : 665 - 675
  • [3] Renal Outcomes With Tenofovir Alafenamide in Liver Transplant Recipients
    Liu, Joanne K.
    Vutien, Philip
    Huang, Daniel Q.
    Ishigami, Masatoshi
    Landis, Charles S.
    Nguyen, Mindie H.
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2023, 21 (02)
  • [4] Tenofovir alafenamide is associated with improved alanine aminotransferase and renal safety compared to tenofovir disoproxil fumarate
    Liang, Lilian Yan
    Yip, Terry Cheuk-Fung
    Lai, Jimmy Che-To
    Lam, Amy Shuk-Man
    Tse, Yee-Kit
    Hui, Vicki Wing-Ki
    Chan, Henry Lik-Yuen
    Wong, Vincent Wai-Sun
    Wong, Grace Lai-Hung
    JOURNAL OF MEDICAL VIROLOGY, 2022, 94 (09) : 4440 - 4448
  • [5] RENAL AND BONE SAFETY OF TENOFOVIR ALAFENAMIDE VS TENOFOVIR DISOPROXIL FUMARATE
    Post, Frank
    Sax, Paul
    Saag, Michael
    Yin, Michael
    Oka, Shinichi
    Koenig, Ellen
    Trottier, Benoit
    Andrade, Jaime
    Cao, Huyen
    Fordyce, Marshall
    SEXUALLY TRANSMITTED INFECTIONS, 2015, 91 : A48 - +
  • [6] Renal safety of tenofovir disoproxil fumarate and entecavir with hepatitis B immunoglobulin in liver transplant patients
    Lee, Juhan
    Park, Jun Yong
    Yang, Seok Jeong
    Lee, Jee Youn
    Kim, Deok Gie
    Joo, Dong Jin
    Kim, Myoung Soo
    Kim, Soon Il
    Lee, Jae Geun
    JOURNAL OF VIRAL HEPATITIS, 2020, 27 (08) : 818 - 825
  • [7] RENAL SAFETY OF TENOFOVIR DISOPROXIL FUMARATE AND ENTECAVIR WITH HEPATITIS B IMMUNOGLOBULIN IN LIVER TRANSPLANT PATIENTS
    Lee, Juhan
    Park, Jun Yong
    Yang, Seok Jeong
    Lee, Jee Youn
    Kim, Deok Gie
    Joo, Dong Jin
    Kim, Myoung Soo
    Kim, Soon Il
    Lee, Jae Geun
    TRANSPLANTATION, 2020, 104 (09) : S540 - S540
  • [8] Tenofovir alafenamide compared to tenofovir disoproxil fumarate, induces dysglycemia, and dyslipidemia in Wistar rats
    Hurchund, Rajendraparsad
    Sibiya, Sinegugu E.
    Owaga, Bernard O.
    Owira, Peter M. O.
    AIDS, 2024, 38 (13) : 1809 - 1818
  • [9] To use entecavir, tenofovir disoproxil fumarate or tenofovir alafenamide: it's all about choosing the right patient!
    Satsangi, Sandeep
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2018, 30 (06) : 689 - 690
  • [10] Efficacy of entecavir, tenofovir disoproxil fumarate, and tenofovir alafenamide in treatment-naive hepatitis B patients
    Hye Yeon Chon
    Sang Hoon Ahn
    Yoon Jun Kim
    Jung-Hwan Yoon
    Jeong-Hoon Lee
    Dong Hyun Sinn
    Seung Up Kim
    Hepatology International, 2021, 15 : 1328 - 1336
12345